And when it comes to prescriptions, a 2025 FAIR Health report shows the percentage of overweight or obese adults prescribed a GLP-1 jumped from 0.3 percent in 2019 to 2.05 percent in 2024 an almost 587 percent increase
Elangovan A, Shah R, Ali SMJ, Katz J, Cooper GS
Our manufacturing approach prioritizes: Skin safety and comfort Reliable adhesion Clean, professional product presentation Partner with The Tape Lab If youre researching GLP-1 support patch manufacturers, transdermal wellness patches, or private-label metabolic support products, The Tape Lab provides a fast, scalable solution backed by adhesive expertise
ACOG Practice Bulletin No
Baseline demographics and clinical data were collected during the 52 weeks before the first medication dispense date
Factors like adherence, diet, exercise, sleep, stress, and genetics all influence outcomes